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Delayed surgery is associated with worse lung cancer outcomes. Social determinants
can influence health disparities. This study aimed to examine the potential racial
disparity and the effects from social determinants on receipt of timely surgery among
lung cancer patients in Louisiana, a southern state in the U.S. White and black
stage I–IIIA non-small cell lung cancer patients diagnosed in Louisiana between 2004
and 2016, receiving surgical lobectomy or a more extensive surgery, were selected.
Diagnosis-to-surgery interval >6 weeks were considered as delayed surgery. Social
determinants included marital status, insurance, census tract level poverty, and census
tract level urbanicity. Multivariable logistic regression and generalized multiple mediation
analysis were conducted. A total of 3,616 white (78.9%) and black (21.1%) patients were
identified. The median time interval from diagnosis to surgery was 27 days in whites and
42 days in blacks (P < 0.0001). About 28.7% of white and 48.4% of black patients
received delayed surgery (P < 0.0001). Black patients had almost two-fold odds of
receiving delayed surgery than white patients (adjusted odds ratio: 1.91; 95% confidence
interval: 1.59–2.30). Social determinants explained about 26% of the racial disparity in
receiving delayed surgery. Having social support, private insurance, and living in census
tracts with lower poverty level were associated with improved access to timely surgery.
The census tract level poverty level a stronger effect on delayed surgery in black patients
than in white patients. Tailored interventions to improve the timely treatment in NSCLC
patients, especially black patients, are needed in the future.
Keywords: non-small cell lung cancer, timely surgery, racial disparity, social determinants, cancer registry
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INTRODUCTION

Institute’s Surveillance, Epidemiology, and End Results (SEER)
program and the National Program of Cancer Registries of
the Centers for Disease Control and Prevention. LTR routinely
collects data on the characteristics, diagnosis, and the first
course treatment of newly diagnosed cancers among Louisiana
residents. This study identified white and black patients who
were diagnosed with stage I-IIIA NSCLC between 2004 and 2016
from the LTR database. Only patients who received surgery of
lobectomy or more extensive surgery were included. Patients who
received neoadjuvant treatment, or who had unknown timing of
treatment initiation were excluded.

Lung cancer is the leading cause of cancer death in the
United States (U.S.), accounting for 24% of all cancer deaths
(1). In 2020, it is estimated that up to 228,820 new cases and
135,720 deaths from lung cancer occurred in the U.S (2). Nonsmall cell lung cancer (NSCLC) represents about 85% of all
lung cancer cases (3). Survival of NSCLC patients has improved
with the advancement of early detection and treatment (4).
Surgical resection is the primary recommended treatment for
patients with stage I-IIIA NSCLC (5). Timely care is an important
indicator of the quality of care recommended by the Institute of
Medicine (5). Delayed surgery is associated with tumor upstaging
and worse survival (4, 6). Patients who receive surgery tend to
have a longer wait time than those not receiving surgery, because
of the multiple staging studies and preoperative examinations
that are required (7, 8). It is of public health importance to
examine the timeliness of NSCLC surgery.
Racial disparities exist in NSCLC diagnosis, treatment, and
outcomes. Black patients are 16% less likely to be diagnosed at
an early stage, 57% less likely to receive guideline concordant
treatment, and 19% less likely to receive surgical treatment, when
compared to their white counterparts. The survival rate is also
lower in black patients than in white patients (9–11). From
2010 to 2015, Louisiana ranked 7th among states in the U.S.
for lung cancer incidence and mortality rate (12). Blacks make
up approximately 1/3 of the population in Louisiana, and have
worse health status than other racial groups (10). Black residents
in Louisiana have a higher lung cancer incidence (68.9 vs. 61.1
per 100,000) and poorer survival compared to black people in the
U.S. on average (13, 14). Additionally, 17.9% of black NSCLC
patients in Louisiana received early diagnosis while 21.4% of
whites received early diagnosis (10). Thus, Louisiana NSCLC
patients are the appropriate population to investigate the racial
disparity in timely surgery of NSCLC.
Social determinants of health are societal factors that
contribute to one’s overall health or the health of the community
(15). It has been argued throughout history that racial health
disparities are not caused by biological difference; rather they
are influenced by societal factors (16). Previous studies have
found that social and economic factors influence disparities
in lung cancer incidence and survival, even more than
biological differences. Several social determinants, including
income, insurance status, marital status, and rural residence,
are associated with the receipt of standard care for NSCLC
(17). This study had three objectives: (1) to investigate whether
there is a racial disparity in receipt of timely surgery among
stage I–IIIA NSCLC patients; (2) if the racial disparity exists, to
examine whether the disparity can be explained by multiple social
determinants; and 3) to explore whether the social determinants
have a differential effect on timely surgery in each racial group.

Variables
The main exposure variable was race (white, black). The outcome
variable was timely receipt of surgery. As we included stage I–IIIA
patients to whom the recommended first definitive treatment
was surgery, and excluded the patients who received neoadjuvant
treatment and those whose timing of treatment initiation was
unclear, we considered that surgery was the first treatment for the
selected patients. The main guidelines for the timing of treatment
initiation of NSCLC patients is to receive surgery within 6 weeks,
as specified by the RAND corporation (18), within 8 weeks by
the British Thoracic Society (19), and within 4–8 weeks by the
American College of Chest Physicians (20). Thus, we used ≤6
weeks as a middle representation across these guidelines (≤6
weeks, >6 weeks).
Social determinants examined in this study included type
of insurance (private, Medicare, Medicaid, no insurance,
unknown), marital status (married, single or divorced or
widowed or other, unknown), census tract level population
under the federal poverty level (<10%, 10–19.9%, ≥20%),
and census tract level urbanicity (urban, rural). Census tract
level urbanicity was determined based on the Census Bureau’s
identification of urban and rural areas. Other covariates included
age at diagnosis (<54, 55–64, 65–74, ≥75), sex, tumor histology
(adenocarcinoma, other), tumor size (<3 cm, 3–7 cm, >7 cm),
American Joint Committee on Cancer (AJCC) stage (I, II,
IIIA), grade (well-differentiated, moderately differentiated,
poorly differentiated/undifferentiated, unknown), lymph node
involvement status (negative, positive), surgery type (resection
of lob, resection extended), and comorbidity (Charlson
Comorbidity Index score of 0, 1, 2+) (21).

Statistical Analysis
We used Chi-square test to compare the categorical variables.
Students’ t-test and Wilcoxon-Mann-Whitney test were applied
to compare the mean and median time interval between tumor
diagnosis and surgical resection by race. We applied three
logistic regression models to examine the racial difference in
receiving timely surgery. In Model 1, we employed a crude
model to examine the racial disparity for delayed surgery.
In Model 2, we controlled for clinical factors, including age,
sex, comorbidity, histology type, tumor size, AJCC stage,
tumor grade, lymph node involvement status, and surgery
type, to examine whether the adjusted odds ratio (OR) of
delayed surgery remained significant for race. As a final step,
social determinants were adjusted in Model 3 to examine

METHODS
Data Source and Study Population
The Louisiana Tumor Registry (LTR) is a population-based
state cancer registry and a participant of the National Cancer
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FIGURE 1 | Conceptual diagram of racial disparity in receiving timely surgery for non-small cell lung cancer patients.

RESULTS

whether the racial disparity could be explained. To examine
the effect of social determinants on delayed surgery in
each racial group, a stratified analysis was conducted among
white and black patients. These analyses were performed
using SAS 9.4 (SAS Institute Inc.), and statistical tests of
significance were based on a 2-sided test with significance levels
of 0.05.
To examine the percentage of racial differences in receiving
timely surgery which was explained by the social determinants,
we conducted general multiple mediation analysis (MMA) to
evaluate the mediating effects. MMA evaluates the mediating
effects under the counterfactual framework, which can report
joint mediation effects through multiple selected mediators
simultaneously, considering the correlation among these
mediators (22). As shown in the conceptual diagram in
Figure 1, race was treated as exposure variable and timely
surgery as outcome variable. Demographic characteristics
(age, sex) were deemed as potential confounders. Clinical
factors (comorbidity, tumor histology, size, stage, grade, lymph
node involvement, and surgery type) and social determinants
(marital status, insurance, census tract poverty level, and
census tract urbanicity) were considered as groups of mediators
in the pathway between race and timely surgery. The total
effect of race on timely surgery was the sum of the direct
effect from race and the indirect effect through each group
of mediators (total effect = direct effect + indirect effect)
(22). The percentage of the total effect explained by each
group of mediators was calculated as the ratio of the indirect
effect divided by the total effect. We used R version 4.0.0
with mma package to conduct the mediation analysis. The
95% confidence interval was obtained by bootstrap with
500 repetitions.

Frontiers in Public Health | www.frontiersin.org

A total of 3,616 patients, including 2,854 (78.9%) white and
762 (21.1%) black patients were included in our study (Table 1).
White patients were more likely to be older than 65 years,
married, have stage I or lymph node negative disease, while
black patients were more likely to be covered by Medicaid,
live in a census tract with higher urbanicity and poverty
level. For both racial groups, over half of patients were male,
without comorbid conditions, diagnosed with adenocarcinoma
and <3 cm tumors, or receiving lobectomy. The median time
interval from diagnosis to surgery was 27 days for whites and
42 days for blacks (P < 0.0001). About 28.7% of white patients
and 48.4% of black patients received surgery after 6 weeks from
diagnosis (P < 0.0001).
Compared to white patients, the OR of receiving surgery
more than 6 weeks after diagnosis for black patients was 2.33
(95% confidence interval [CI]: 2.00-2.74) in the crude model,
which decreased to 2.19 (95% CI: 1.84–2.60) after controlling
demographic and tumor characteristics. With additional
adjustment of social determinants, the OR remained significant
at 1.91 (95% CI: 1.59–2.30) (Table 2). Being unmarried (OR:
1.27, 95% CI: 1.08–1.48), having Medicare or other public
insurance (OR:1.20, 95% CI: 1.01–1.44), having Medicaid
insurance (OR:1.67, 95% CI: 1.31–2.14), no insurance (OR:3.03,
95% CI: 1.98–4.65), and living in high poverty level area (OR
1.43, 95% CI: 1.08–1.48) were associated with a significantly
higher likelihood of delayed surgery. After stratification by race,
living in a high poverty census tract was significantly associated
with delayed surgery in both racial groups, but with a higher
OR in blacks (OR: 1.91, 95% CI: 1.09–3.35) than in whites (OR:
1.37, 95% CI: 1.10–1.71) (Table 3). Among white patients, the
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TABLE 1 | Characteristics of Louisiana stage I–IIIA non-small cell lung cancer patients by race, 2004–2016, n (%).

N

Total

White

Black

3,616

2,854 (78.9)

762 (21.1)

496 (13.7)

353 (12.4)

143 (18.8)

P-value

Demographic factors
Age
<54

<0.0001

55–64

980 (27.1)

722 (25.3)

258 (33.9)

65–74

1463 (40.5)

1176 (41.2)

287 (37.7)

75+

677 (18.7)

603 (21.1)

74 (9.7)

Female

1,913 (52.9)

1,501 (52.6)

412 (54.1)

Male

1,703 (47.1)

1,353 (47.4)

350 (45.9)

Adenocarcinoma

2,186 (60.5)

1,705 (59.7)

481 (63.1)

Non-adenocarcinoma

1,430 (39.5)

1,149 (40.3)

281 (36.9)

<3 cm

2,149 (59.4)

1,702 (59.6)

447 (58.7)

3–7 cm

1,289 (35.6)

1,014 (35.5)

275 (36.1)

>7 cm

178 (4.9)

138 (4.9)

40 (5.3)

Stage I

2,447 (67.7)

1,964 (68.8)

483 (63.4)

Stage II

750 (20.7)

568 (19.9)

182 (23.9)

Stage IIIA

419 (11.6)

322 (11.3)

97 (12.7)

Negative

2,758 (76.3)

2,202 (77.2)

556 (73.0)

Positive

858 (23.7)

652 (22.9)

206 (27.0)

420 (11.6)

335 (11.7)

85 (11.2)

Moderately differentiated

1,467 (40.6)

1,170 (41.0)

297 (39.0)

Poorly/undifferentiated

1,449 (40.1)

1,129 (39.6)

320 (42.0)

280 (7.7)

220 (7.7)

60 (7.9)

3,200 (88.5)

2,529 (88.6)

671 (88.1)

416 (11.5)

325 (11.4)

91 (11.9)

0

2,000 (55.3)

1,587 (55.6)

413 (54.2)

1

1,053 (29.1)

844 (29.6)

209 (27.4)

563 (15.6)

423 (14.8)

140 (18.4)

Married

2,111 (58.4)

1,798 (63.0)

313 (41.1)

Single/divorced/widowed/other

1,395 (38.6)

968 (33.9)

427 (56.0)

110 (3.0)

88 (3.1)

22 (2.9)

Private

1,347 (37.3)

1,100 (38.5)

247 (32.4)

Medicare/other public

Sex

0.47

Clinical factors
Tumor histology

0.09

Tumor size

0.84

AJCC stage

0.02

Lymph node involvement

0.02

Grade
Well-differentiated

Unknown

0.64

Surgery type
Resection of lobe
Resection extended

0.67

Comorbidity score

2+

0.05

Social determinants
Marital status

Unknown

<0.0001

Insurance

<0.0001
1,682 (46.5)

1,390 (48.7)

292 (38.3)

Medicaid

409 (11.3)

245 (8.6)

164 (21.5)

No insurance

104 (2.9)

67 (2.4)

37 (4.9)

Unknown

74 (2.0)

52 (1.8)

22 (2.9)

902 (24.9)

839 (29.4)

63 (8.3)

1,407 (38.9)

1,225 (42.9)

182 (23.9)

Census tract level poverty
<10%
10–19.9%

<0.0001

(Continued)
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TABLE 1 | Continued
Total

White

Black

1,307 (36.2)

790 (27.7)

517 (67.9)

Urban

2,597 (71.8)

1,953 (68.4)

644 (84.5)

Rural

1,019 (28.2)

901 (31.6)

118 (15.5)

Time interval from diagnosis to surgery, mean (std)

40.8 (44.8)

32.7 (35.6)

47.1 (43.0)

29 (6–50)

27 (3–46)

42 (14–70)

<.0001

32.9

28.7

48.4

<0.0001

≥20%
Census tract level urbanicity

Time interval from diagnosis to surgery, median (Q1–Q3)
Receiving surgery >6 weeks from diagnosis

P-value

<0.0001

<0.0001

AJCC, American Joint Committee on Cancer; std, standard deviation; Q1, the first quartile; Q3, the third quartile.

1.48 of delayed surgery in blacks than in whites. In Louisiana,
black patients had 1.92 times the odds of having delay in NSCLC
surgery compared to white patients, after adjusting for clinical
factors and social determinants.
We examined the impact from several social determinants on
timely surgery and whether the examined social determinants
could explain the observed racial disparity. Unsurprisingly,
private insurance was a significant predictor of the receipt of
timely surgery or guideline-concordant care in lung cancer
patients (17). Medicaid insured patients tended to experience
the largest delay in receiving treatment (17). In a national
study, compared to NSCLC patients with private insurance, the
diagnosis-to-surgery interval was 2.3 days longer for Medicare
patients, 10.8 days longer for Medicaid patients, and 7.8 days
for longer for patients who were uninsured or whose insurance
status was unknown (9). Another study found that patients
covered by both Medicare and Medicaid were less likely to receive
timely surgical treatment than patients with only Medicare
(23). Insurance was also a significant predictor of delayed
surgery in our study, however, we additionally found different
effects of insurance coverage on timely treatment in two racial
groups. Among white patients, Medicaid covered patients had
two times the odds and patients without insurance had four
times the odds of having delayed surgery compared to their
privately insured counterparts. Compared to black patients
with private insurance, the odds of receiving surgery more
than 6 weeks after diagnosis was 1.5 times for the Medicare
group, but no significant differences were observed for those
with Medicaid or those without insurance. The small sample
size of black patients may be a reason for a lack of finding
significant ORs. However, the point estimates of the ORs in
these two groups were also lower in black patients than in
white patients. Another possible reason is the availability of
charity hospitals in Louisiana, which provide medical services
to uninsured residents. As the majority of patients receiving
care through charity hospitals are black, the black uninsured
patients may have had more healthcare access benefits through
the charity hospitals than white uninsured patients. This could
be a possible explanation of the insignificant odds ratios
of receiving delayed surgery for black Medicaid covered or
uninsured patients compared to black privately insured patients
(in contrast with the highly significant odds ratios observed in
white patients). The adoption of public policies, such as the

OR of receiving surgery more than 6 weeks after diagnosis was
significant for those with Medicare coverage (OR: 2.11, 95%
CI: 1.56–2.85) and no insurance coverage (OR: 4.15, 95% CI:
2.46–7.04), compared to those with private insurance coverage.
Among black patients, those with Medicaid coverage had a
significantly higher risk of delayed surgery (OR: 1.48, 95% CI:
1.01-2.16) (Table 3).
From the mediation analysis, the total effect of race on timely
surgery was 0.905 (95% CI; 0.735–1.091), the direct effect was
0.652 (95% CI: 0.470–0.854), and the indirect effect through
clinical factors and social determinants were 0.009 (95% CI:
−0.013–0.028), and 0.235 (95% CI: 0.151–0.321). The percentage
of racial disparities transmitted through social determinants
was 25.97%.

DISCUSSION
With population-based data collected by the state cancer registry,
we found that black stage I-IIIA NSCLC patients had almost twofold odds of receiving delayed surgery, compared to their white
counterparts. Multiple social determinants, including insurance,
marital status, and poverty level in the census tract, were
significant predictors of delayed surgery, but these factors did not
fully explain the racial disparity in delayed NSCLC surgery in a
U.S. southern state.
Our findings of a higher risk of delayed surgery among
black patients are consistent with a few studies using nationwide
databases. However, the magnitude of the racial disparity was
more profound in Louisiana than in U.S. on average. One recent
study using 2008–2013 National Cancer Data Base (NCDB)
reported a median time from diagnosis to surgical resection of
26 days for whites and 31 days for blacks (p < 0.0001) (9). White
patients in Louisiana had a similar median wait time for surgery
compared to white patients in the U.S. (27 days vs. 26 days), but
black patients in Louisiana experienced a 30% longer wait time
compared to black patients in the U.S. (42 days vs. 31 days). The
larger difference in diagnosis-to-surgery interval between black
and white patients in Louisiana is also reflected in the higher
OR found in our study. One study using SEER-Medicare data
reported that black NSCLC patients had 1.18 times the odds
of receiving delayed treatment compared to white patients (23).
Another study using NCDB data reported an adjusted OR of
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TABLE 2 | Continued

TABLE 2 | Odds ratio (95% confidence interval) of receiving surgery 6 weeks or
later after diagnosis for non-small cell lung cancer patients.

Model 1*
Model 2†

Model 1*

Model 2†

Model 3¶

Model 3¶
1.43 (1.17, 1.76)

≥20%
Race

Census tract urbanicity, %

White

1

1

1

Urban

1

Black

2.33 (2.00, 2.74)

2.19 (1.84, 2.60)

1.91 (1.59, 2.30)

Rural

1.02 (0.86, 1.21)

1

1

55–64

1.24 (0.98, 1.58)

1.40 (1.09, 1.80)

65–74

1.14 (0.90,1.43

1.27 (0.98, 1.64)

75+

1.34 (1.03,1.74)

1.48 (1.11, 1.97)

Age, %
<54

†

*Crude model; Adjusted age at diagnosis, sex, marital status, histology, tumor
size, AJCC stage, tumor grade, lymph node involvement status, surgery type, and
comorbidity. ¶ Additionally adjusted for insurance, marital status, census tract level poverty
and urbanicity.

Sex, %
Female
Male

1

1

0.99 (0.86,1.16)

0.93 (0.80, 1.08)

Affordable Care Act (ACA) can improve access to high quality
healthcare for marginalized populations receiving disparate care.
Previous studies have shown that cancer survivors in Medicaid
expansion states were more likely to be insured, to have access
to care, and to be diagnosed at an early stage of disease than
those in non-expansion states (17, 24). Louisiana was one of
the states with earliest initiation of ACA expansion in the
country (23).
Our findings indicate that those who are single, widowed or
divorced are more likely to receive delayed surgical treatment
for NSCLC. Being married or living with a partner is an
indication of social support. Social support has been found to
be a protective factor for the prevention and maintenance of
many diseases (25). Previous studies reported that being married
is a predictor of receiving standard care and better outcomes
(26–28), while experiencing social isolation or loneliness has
a negative influence on lung cancer patients (29). In our
study, being married showed a similar protective effect for
receiving timely surgery in both white and black patients,
while the insignificance of the OR among black patients
may be due to the smaller sample size of black patients in
our study.
Our study revealed that living in census tracts with a
higher proportion of the population living above the national
poverty level was associated with higher risk of receiving
delayed surgery, and the relationship showed a dose-response
effect. This finding is consistent with previous research that
evaluated both individual level household income and censustract level income (9, 30). Even among Medicare covered
NSCLC patients who have equal health care access, income
level is positively associated with timely treatment (23). After
stratification by race, we found that the impact from income
was even stronger among black patients, while the strength of
the association among white patients was similar to findings
from national data (23). Although urban residence was associated
with lower lung cancer incidence and better outcomes (31,
32), similar to another study (23), living in urban census
tracts was not a significant predictor of timely surgery in
our study.
Unsurprisingly, social determinants of health are important
contributing factors of racial disparities in cancer prognosis
and outcomes (33–35). It has also been found that social
determinants account for racial disparities in receiving

Tumor histology, %
Adenocarcinoma
Non-adenocarcinoma

1

1

1.06 (0.90,1.23)

1.02 (0.87, 1.20)

Tumor size, %
<3 cm

1

1

3–7 cm

1.27 (1.09, 1.49)

1.27 (1.08, 1.49)

>7 cm

0.90 (0.62, 1.29)

0.93 (0.64, 1.34)

AJCC stage, %
Stage I

1

1

Stage II

1.16 (0.89, 1.51)

1.09 (0.84, 1.42)

Stage IIIA

1.46 (1.03, 2.10)

1.43 (0.99, 2.05)

Lymph node involvement, %
Negative

1

1

Positive

0.90 (0.67, 1.20)

0.93 (0.69, 1.25)

Grade, %
Well-differentiated

1

1

Moderately
differentiated

1.02 (0.80, 1.31)

0.97 (0.76, 1.25)

Poorly/undifferentiated

1.49 (1.10, 2.10)

1.08 (0.84, 1.40)

Surgery type, %
Resection of lobe
Resection extended

1

1

0.87 (0.69, 1.10)

0.85 (0.67, 1.08)

Charlson comorbidity index, %
0

1

1

1

1.15 (0.98, 1.36)

1.11 (0.94, 1.31)

2+

1.39 (1.14, 1.70)

1.32 (1.08, 1.62)

Marital status, %
Married

1

Single/divorced/widowed/other

1.27 (1.08, 1.48)

Unknown

0.67 (0.41, 1.09)

Insurance, %
Private

1

Medicare/other public

1.20 (1.01, 1.44)

Medicaid

1.67 (1.31, 2.14)

No insurance

3.04 (1.98, 4.65)

Unknown

0.66 (0.34, 1.20)

Census tract poverty, %
<10%
10–19.9%

1
1.17 (0.96, 1.43)
(Continued)
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guideline-recommended curative treatment for NSCLC,
breast, and prostate cancer, specifically with insurance status,
geographical access, and SES factors having been identified
as contributors (36–39). Although black NSCLC patients are
less likely to receive guideline concordant surgical treatment
than whites, the literature on the role of social determinants
in the receipt of timely cancer was limited (27, 40, 41). Black
women are less likely on average to receive hormone therapy,
chemotherapy, radiotherapy and surgical treatment for breast
cancer in a timely manner as compared to white women (42).
Additionally, both high and low-risk black prostate cancer
patients experienced longer wait times from diagnosis to
definitive treatment compared to white patients (43). One
study reported that the differences in social determinants
explained about 26% of racial disparities, while in our study,
the majority of the racial disparity was not explained by the
measured mediators. The remaining unexplained racial disparity
indicates that there are other social-cultural differences between
the two racial groups that influence the timeliness of surgical
receipt for NSCLC. One limitation of our study is the lack of
information on patients’ perceptions and attitudes toward cancer
treatment. Black patients may be reluctant to seek care due to
stigma, distrust in physicians, and negative perceptions about
surgery. Previous research indicates that black, at-risk NSCLC
patients commonly seek a second opinion or are skeptical of
information provided to them by a physician with whom they
had no previous relationship with (44). Black patients also
tend to have negative perceptions about surgical treatment,
and believe it to be riskier than radiation or chemotherapy
treatment (45). Future research could examine whether these
risk factors can explain racial disparity in timely NSCLC
surgery and design tailored intervention to improve the timely
treatment in both racial groups. Another limitation of this
study is that we did not have data on several individual-level
social determinants, such as household income, education,
and employment. Lower educational level is associated with
decreased odds of having surgery and poorer survival rates
(32). Population-based administrative data or cancer registry
data usually do not have information on such individual-level
variables. Surveys or additional medical record data extraction
are needed to address this gap. Despite these limitations, our
study is the first to investigate the impact of social determinants
of health on receipt of timely NSCLC surgical treatment
by race. Our findings can provide important evidence for
future intervention.
In summary, while timely surgery is an important predictor
of the prognosis of curable NSCLC, we found a significant
racial disparity among Louisiana patients. Black patients had
almost twice the odds of receiving delayed surgery than white
patients, after adjusting for demographic, clinical, and social
factors. Having social support, private insurance, and living
in census tracts with higher income level was associated
with improved access to timely surgery, but these factors
explained only about 26% of the observed racial disparity.
Majority of racial disparity remained unexplained. As the
state of Louisiana has high proportion of black population
and high lung cancer incidence, the findings from this

TABLE 3 | Adjusted odds ratios (95% confidence interval) of receiving surgery 6
weeks or later after non-small cell lung cancer diagnosis, stratified by race.
White

Black

Age
1

1

1.43 (1.05, 1.94)

1.26 (0.81, 1.96)

<54
55–64
65–74

1.22 (0.90, 1.66)

1.39 (0.87, 2.21)

75+

1.64 (1.17, 2.28)

0.92 (0.49, 1.70)

Sex
Female
Male

1

1

0.99 (0.83, 1.18)

0.76 (0.55, 1.05)

1

1

1.12 (0.94, 1.34)

0.74 (0.53, 1.03)

Tumor histology
Adenocarcinoma
Non-adenocarcinoma
AJCC Stage
Stage I

1

1

Stage II

1.16 (0.85, 1.59)

0.90 (0.53, 1.03)

Stage IIIA

1.43 (0.93, 2.19)

1.36 (0.69, 2.71)

Tumor size
<3cm

1

1

3–7cm

1.26 (1.05, 1.52)

1.30 (0.93, 1.81)

>7cm

0.96 (0.63, 1.47)

0.80 (0.39, 1.66)

Lymph node involvement
Negative

1

1

Positive

0.96 (0.68, 1.35)

0.82 (0.47, 1.44)

Grade
Well-differentiated

1

1

Moderately differentiated

0.99 (0.74, 1.33)

0.84 (0.50, 1.40)

Poorly/undifferentiated

1.10 (0.80, 1.47)

0.98 (0.57, 1.66)

Surgery type
Resection of lobe
Resection extended

1

1

0.90 (0.68, 1.18)

0.72 (0.44, 1.17)

Comorbidity index
0

1

1

1

1.11 (0.91, 1.34)

1.13 (0.80, 1.61)

2+

1.33 (1.05, 1.70)

1.29 (0.86, 1.94)

Marital status
Married
Single/divorced/widowed/other

1

1

1.26 (1.05, 1.52)

1.21 (0.87, 1.68)

Insurance
Private

1

1

1.123 (0.92, 1.38)

1.47 (1.01, 2.15)

Medicaid

2.13 (1.57,2.88)

1.16 (0.75, 1.79)

No insurance

4.10 (2.42, 6.95)

1.55 (0.75, 3.21)

Unknown

0.67 (0.31,1.44)

0.74 (0.28, 1.94)

Medicare/other public

Census tract poverty
1

1

10–19.9%

1.14 (0.92, 1.40)

1.49 (0.80, 2.75)

≥20%

1.37 (1.10, 1.72)

1.90 (1.08, 3.34)

<10%

Census tract urbanicity
Urban

1

1

Rural

0.97 (0.81, 1.17)

1.33 (0.87, 2.02)
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